GlaxoSmithKline formed a Joint Venture with Pfizer in 2019

GSK CEO: Pfizer venture creates value for both our consumer and pharma businessesПодробнее

GlaxoSmithKline and Vir start phase 2/3 study for Covid-19 antibody drugПодробнее

Pfizer, GlaxoSmithKline join forces on OTC drugsПодробнее

GlaxoSmithKline CEO on price wars and Pfizer/Allergan dealПодробнее

Corporate Level Strategy - Different strategies used at the Corporate LevelПодробнее

How Pfizer and BioNTech made history with their vaccineПодробнее

VACCINES | This is the weird way Pfizer and GSK do businessПодробнее

Emma Walmsley summarises our agreement with Pfizer to form a Consumer Healthcare Joint Venture.Подробнее

Watch CNBC's full interview with GSK CEO Emma Walmsley about the Pfizer mergerПодробнее

GSK & PFIZER JV announcedПодробнее

GSK and Sanofi joining forces to develop a vaccine for COVID-19Подробнее

Prix Galien USA 2019 / Best Pharmaceutical Product - GlaxoSmithKline - SHINGRIXПодробнее

Glaxo CEO on Pfizer deal: Separation should happen within 3 yearsПодробнее

Key Points to consider before diving into a Builder Joint VentureПодробнее

GlaxoSmithKline (GSK) - Stock AnalysisПодробнее

The COVID-19 Vaccines from Pfizer-BioNTech and Moderna: What's in Them and How Do They Work?Подробнее

We're expecting to get at least six drug approvals from the FDA in 2020: GlaxoSmithKline CEOПодробнее

What Clinicians Need to Know About Pfizer-BioNTech and Moderna VaccinesПодробнее

GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolioПодробнее

Drugmaker GSK to split in two after folding in Pfizers consumer unitПодробнее